FDA advisors to meet this month to discuss COVID shot for children ages 5-11

October 7th, 20210 WASHINGTON, D.C. — The U.S. Food and Drug Administration has confirmed Oct. 26 for its panel of outside advisers to meet and discuss the use of Pfizer’s COVID-19 vaccine in children as young as 5. If approved by that advisory panel, children ages of 5- 11-years-old, numbering around 28 million, will begin receiving the two-dose...